Kinsuke Tsuda Selected Research

Kinsuke Tsuda Research Topics

Disease

10	Type 2 Diabetes Mellitus (MODY) 04/2022 - 05/2002
9	Hypertension (High Blood Pressure) 02/2012 - 08/2002
8	Obesity 04/2012 - 07/2002
6	Diabetes Mellitus 12/2008 - 06/2003
5	Insulin Resistance 02/2012 - 07/2002
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2012 - 04/2011
2	Body Weight (Weight, Body) 03/2013 - 04/2008
2	Dyslipidemias (Dyslipidemia) 02/2012 - 08/2008
2	Hypercholesterolemia 01/2011 - 12/2008
2	Hyperlipidemias (Hyperlipidemia) 10/2009 - 04/2008
2	Hyperglycemia 04/2008 - 06/2003
2	Type 3 Maturity-Onset Diabetes of the Young 08/2006 - 12/2004
2	Mason-Type Diabetes 12/2004 - 05/2002
1	Diabetes Complications 04/2022
1	Septic Shock (Toxic Shock Syndrome) 08/2017
1	Hypoxia (Hypoxemia) 01/2014
1	Hyperoxia 01/2014
1	Colitis 03/2013
1	Ulcerative Colitis 03/2013
1	Neoplasms (Cancer) 04/2012
1	Chronic Disease (Chronic Diseases) 04/2012
1	Hypertriglyceridemia 03/2012
1	Birth Weight (Birth Weights) 02/2012
1	Inflammation (Inflammations) 01/2011
1	Hyperinsulinism (Hyperinsulinemia) 04/2008
1	Essential Hypertension 04/2005
1	Hyperplasia 06/2003
1	Stroke (Strokes) 08/2002
1	Overnutrition 07/2002

Drug/Important Bio-Agent (IBA)

7	Glucose (Dextrose)FDA LinkGeneric 05/2016 - 11/2002
5	Messenger RNA (mRNA)IBA 01/2014 - 10/2009
4	Insulin (Novolin)FDA Link 02/2012 - 03/2003
3	LipidsIBA 01/2011 - 04/2005
3	Pharmaceutical PreparationsIBA 12/2008 - 07/2003
3	Hepatocyte Nuclear FactorsIBA 08/2006 - 05/2002
2	CarbohydratesIBA 04/2022 - 06/2003
2	Proteins (Proteins, Gene)FDA Link 01/2014 - 09/2004
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 02/2012 - 04/2011
2	Blood Glucose (Blood Sugar)IBA 02/2012 - 02/2010
2	pitavastatin (itavastatin)FDA Link 01/2011 - 12/2008
2	C-Reactive ProteinIBA 01/2011 - 12/2008
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2011 - 12/2008
2	Oxygen (Dioxygen)IBA 02/2010 - 03/2007
2	Hepatocyte Nuclear Factor 1-alpha (Hepatocyte Nuclear Factor 1 alpha)IBA 08/2006 - 12/2004
2	Hepatocyte Nuclear Factor 1-betaIBA 08/2006 - 12/2004
1	Glucagon-Like Peptide 1 (GLP 1)IBA 07/2019
1	LipopolysaccharidesIBA 08/2017
1	Uncoupling Protein 2IBA 01/2014
1	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 01/2014
1	pimonidazoleIBA 01/2014
1	DNA (Deoxyribonucleic Acid)IBA 01/2014
1	GlucokinaseIBA 01/2014
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2014
1	Glutamine (L-Glutamine)FDA Link 03/2013
1	OligosaccharidesIBA 03/2013
1	Drinking WaterIBA 03/2013
1	Dextran SulfateIBA 03/2013
1	AdipokinesIBA 04/2012
1	TocotrienolsIBA 04/2012
1	Vitamin E FDA LinkGeneric 04/2012
1	HDL CholesterolIBA 02/2012
1	Polytetrafluoroethylene (Teflon)FDA Link 02/2012
1	Triglycerides (Triacylglycerol)IBA 02/2012
1	Interleukin-18 (Interleukin 18)IBA 01/2011
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 12/2008
1	SaltsIBA 08/2008
1	PotassiumIBA 08/2008
1	Fatty Acids (Saturated Fatty Acids)IBA 08/2008
1	CholesterolIBA 08/2008
1	MagnesiumIBA 08/2008
1	AdiponectinIBA 04/2008
1	corosolic acidIBA 04/2008
1	PPAR gammaIBA 04/2008
1	PPAR alphaIBA 04/2008
1	Adrenergic Receptors (Adrenergic Receptor)IBA 09/2006
1	G-protein beta3 subunitIBA 04/2005
1	Transcription Factors (Transcription Factor)IBA 12/2004
1	Genetic Markers (Genetic Marker)IBA 09/2004
1	Oligo-1,6-Glucosidase (Isomaltase)IBA 06/2003
1	DisaccharidasesIBA 06/2003
1	Sucrase (Sucrose alpha-D-Glucohydrolase)IBA 06/2003
1	Streptozocin (Streptozotocin)FDA Link 06/2003
1	Advanced Glycation End ProductsIBA 08/2002
1	Free RadicalsIBA 08/2002
1	OPB 9195IBA 08/2002
1	gastric inhibitory polypeptide receptorIBA 07/2002
1	Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA 07/2002
1	Anti-Obesity Agents (Antiobesity Drugs)IBA 07/2002

Therapy/Procedure

2	Nutrition Therapy (Medical Nutrition Therapy) 04/2022 - 01/2006
1	Exercise Therapy (Therapy, Exercise) 04/2022
1	Drug Therapy (Chemotherapy) 07/2019
1	Therapeutics 03/2013